| Ms Linda C Johnson, CRNA | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (603) 650-5922 | |
| Not Available |
| Full Name | Ms Linda C Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619906096 | NPI | - | NPPES |
| 0009915 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 025101-23-11 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Linda C Johnson, CRNA 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 650-5922 | Ms Linda C Johnson, CRNA 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 650-5922 |
News Archive
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.
EntreMed, Inc., a clinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer, today reported that three months following administration with ENMD 0996, preclinical animal models showed inhibition of metastases. Data presented demonstrated that ENMD 0996 specifically blocks the activity of basic fibroblast growth factor (FGF-2), a naturally-occurring protein that stimulates angiogenesis, but had no effect on other angiogenesis stimulators.
As Western countries gear up for a second wave of the coronavirus disease (COVID-19) pandemic, a new study shows that this time around, the worst-hit in terms of case numbers is the young adult age group, between 18 and 29 years. This finding could be crucial in framing dynamic public health measures, which will contain and help limit rising cases.
› Verified 6 days ago
Patrick C Keane, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 215-589-0469 | |
Frederic Jon Schaafsma, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 | |
Jeffrey C. Horstman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 | |
Sarah Marie Zack Hewitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Anesthesiology, Lebanon, NH 03756 Phone: 603-650-5922 | |
Mr. Gustaaf C Vansoestbergen, CRNA MSN MPA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 | |
Mr. Thomas Reyes Iv, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Anesthesiology, Lebanon, NH 03756 Phone: 603-650-5922 | |
Ms. Katy Ann Taylor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 |